Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections

Mediators of Inflammation

Volumn 13, Issue 4, 2004, Pages 235-240

  Cardoni, Rita L ^a   Antúnez, María Inés ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

6 Keto prostaglandin F1 ; Mice; Nitric oxide; Prostaglandin F2 ; Thromboxane B2; Trypanosoma cruzi

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; METABOLITE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SKELETAL MUSCLE; SPLEEN CELL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ACUTE DISEASE; ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; DINOPROSTONE; DISEASE SUSCEPTIBILITY; EPOPROSTENOL; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MUSCLE, SKELETAL; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPECIES SPECIFICITY; SPLEEN; THROMBOXANE A2; THROMBOXANE B2;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 9644254077     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09637480400003022     Document Type: Article

References (38)

1. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American Trypanosomiasis. Adv Parasitol 1968; 6: 63-116.
2. + Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect Immun 2000; 68: 197-204.
3. Meyer Zum Büschenfelde C, Cramer S, Trumpfheller C, Fleischer B, Frosch S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-γ) production. Clin Exp Immunol 1997; 110: 378-385.
4. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12: 59-63.
5. Muñoz Fernández MA, Fernández MA, Fresno M. Synergism between tumor necrosis factor-α and interferon-γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992; 22: 301-307.
6. Cardoni RL, Antúnez MI, Morales C, Nantes IR. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1997; 56: 329-334.
7. Vespa GNR, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994; 62: 5177-5182.
8. Tarleton RL. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2 producing cells. J Immunol 1988; 140: 2763-2768.
9. Truyens C, Angelo Barrios A, Torrico F, Van Damme J, Heremans H, Carlier Y. Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: Effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect Immun 1994; 62: 692-696.
10. Hunter CA, Slifer T, Araujo F. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun 1996: 64: 2381-2386.
11. Cardillo F, Voltarelli JC, Reed SG, Silva JS. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996; 64: 128-134.
12. Silva JS, Vespa GNR, Cardoso MAG, Aliberti JCS, Cunha FQ. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995; 63: 4862-4867.
13. Tanowitz HB, Burns ER, Sinha AK, et al. Enhanced platelet aggregation in Chagas disease: a potencial pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 1990; 43: 274-281.
14. 2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglaindins 1995; 49: 141-153.
15. Melo RC, D'Avila H, Fabrino DL, Almeida PE, Bozza PT. Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 2003; 35: 59-67.
16. Farrel JP, Kirkpatrick CE. Experimental cutaneous leishmaniasis. II A possible role of prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol 1987; 138: 902-907.
17. Reiner NE, Malemud CJ. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxigenase and lipoxygenase pathways. J Immunol 1985; 134: 556-562.
18. Fierer J, Salmon JA, Askonas BA. African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages. Clin Exp Immunol 1984; 58: 548-556.
19. 1α production in experimental acute Plasmodium bergei infection in hamsters. Thromb Haemost 1984; 51: 362-365
20. Wolf JE, Massof SE, Peters SP. Alterations in murine arachidonic acid metabolism following ingestion of nonviable Hystoplasma capsulatum. Infect Immun 1992; 60: 2559-2564.
21. 2 y reversal by injection of Indomethacin, muramyl dipeptide, or interferon-γ. J Immunol 1986; 136: 1820-1827.
22. Buckner FS, Wilson AJ, Van Voorhis WC. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for β-galactosidase. Infect Immun 1999; 67: 403-409.
23. Davies P, Bailey PJ, Goldenberg MM, Ford Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol 1984; 2: 335-357.
24. Lonardoni CMV, Russo M, Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun 2000; 68: 6355-6361.
25. 2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha. J Leukoc Biol 1995; 58: 217-224.
26. Rossi MA, Gonzalves S, Do Santos RR. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 1984; 114: 209-216.
27. Morris SA, Tanowitz HB, Wittner M, Bilezibian JP. Pathophysiological insights into the cardiomiopathy of Chagas' disease. Circulation 1990; 6: 1900-1909.
28. Aliberti JC, Machado FS, Gazzinelli RT, Teixeira MM, Silva JS. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun 1999; 67: 2810-2814.
29. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150.
30. Endo T, Ogushi F, Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ. J Immunol 1996; 156: 2240-2246.
31. Niiro H, Otsuka T, Kuga S, et al. IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int Immunol. 1994; 6: 661-664.
32. Antúnez MI, Cardoni RL. The early IFN-γ production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol Lett 2001; 79: 193-200.
33. Antúnez MI, Cardoni RL. IL-12 and IFN-γ production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol Lett 2000; 71: 103-109.
34. Dinarello CA. Modalities for reducing IL-1 activity in diseases. Immunol Today 1993; 14: 260-264.
35. Borges MM, Kloetzel JK, Andrade Jr HF, Tadokoro CE, Pinge-Filho P, Abrahamsohn I. Prostaglandin and nitric oxide regulate TNF-α production during Trypanosoma cruzi infection. Immunol Lett 1998; 63: 1-8.
36. Pinge-Filho P, Tadokoro CE, Abrahamsohn IA. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol 1999; 193: 90-98.
37. Chandra M, Tanowitz HB, Petkova SB, et al. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuén strain). Int J Parasitol 2002; 32: 897-905.
38. Hölscher C, Köhler G, Müller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 1998; 66: 1208-1215.